Latest News
TB-CHAMP trial finds first-ever safe and effective treatment to prevent multidrug-resistant TB in children
The trial found that levofloxacin, taken for six months once daily, substantially reduced the risk of developing drug-resistant TB.
'25 at 25': Extending the use of drugs - repurposing and beyond
As the final instalment of our 25 at 25 series, we look back at some of the successes of trials we have run that have tested using drugs beyond their original licence.
'25 at 25': PROUD - preventing HIV infections
We look back on the remarkable success of the PROUD study as part of our ’25 at 25’ series celebrating the MRC Clinical Trials Unit’s 25th anniversary.
How people from the LGBT+ community contributed to HIV research
This World AIDS Day, read Sheena McCormack’s story of how she became involved in HIV research and learn about key breakthroughs in the field.
OCTOPUS trial reaches recruitment milestone
OCTOPUS has reached its goal of recruiting 375 people with progressive MS in the first stage of the trial. It will now seamlessly transition into the next stage.